| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/25/2012 | CN102423318A Chlorite in the treatment of neurodegenerative disease |
| 04/25/2012 | CN102423295A 一种含有长春西汀的小容量注射液组合物及其制备方法 A vinpocetine small volume injection containing composition and its preparation method |
| 04/25/2012 | CN102423213A 一种具有防治失眠功效的药枕 Having a pillow efficacy of prevention and treatment of insomnia |
| 04/25/2012 | CN102133339B Traditional Chinese medicine preparation for treating migraine |
| 04/25/2012 | CN102018837B 一种治疗偏头痛的中药复方制剂及其制备方法 A traditional Chinese medicine and its preparation method for migraine treatment |
| 04/25/2012 | CN101972259B 马钱子碱及其衍生物在制备治疗酒精滥用和依赖药物中的应用 Strychnine and its derivatives in the treatment of alcohol abuse and dependence preparation of a medicament |
| 04/25/2012 | CN101966298B 一种治疗风寒麻木的中药 A method of treating cold numbing medicine |
| 04/25/2012 | CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free |
| 04/25/2012 | CN101804177B Anti-depressive traditional Chinese medicinal composition and dripping pill |
| 04/25/2012 | CN101579349B 一种中药制剂 A traditional Chinese medicine preparation |
| 04/25/2012 | CN101574395B 一种采用高电压脉冲电场技术生产五味子提取物的方法 A method using high voltage pulsed electric field technology to produce extracts of Schisandra |
| 04/25/2012 | CN101524394B 雀嘴茶制剂及其应用 Sparrow mouth tea preparation and its application |
| 04/25/2012 | CN101472906B 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪 As for the treatment of cognitive impairment, with binding to serotonin reuptake, 1- [2- (2,4-Dimethyl-phenylsulfanyl) 5-ht3 and 5-ht1a active compounds - benzene yl] piperazine |
| 04/25/2012 | CN101434649B 一种环七肽及其制备方法和应用 A cyclic heptapeptide and its preparation method and application |
| 04/25/2012 | CN101426774B Azolecarboxamide derivative |
| 04/25/2012 | CN101397295B 作为组蛋白去乙酰化酶抑制剂的2-吲哚满酮衍生物、其制法和用途 As a histone deacetylase inhibitor 2-indolinone derivatives, their preparation and use |
| 04/25/2012 | CN101392027B 一种治疗阿尔茨海默病的融合蛋白及其制备方法 A fusion protein of Alzheimer's disease and its preparation method of treatment |
| 04/25/2012 | CN101032559B 益心健脾中成药的制备方法 Yixin spleen preparation of proprietary Chinese medicines |
| 04/24/2012 | US8163958 Levodopa prodrugs, and compositions and uses thereof |
| 04/24/2012 | US8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease |
| 04/24/2012 | US8163932 Substituted indolealkanoic acids |
| 04/24/2012 | US8163909 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 04/24/2012 | US8163762 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 04/24/2012 | US8163752 Tricyclic anilide heterocyclic CGRP receptor antagonists |
| 04/24/2012 | US8163751 Acylated indanyl amines and their use as pharmaceuticals |
| 04/24/2012 | US8163737 CGRP receptor antagonists |
| 04/24/2012 | US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 04/24/2012 | US8163729 Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 04/24/2012 | US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/24/2012 | US8163701 Prodrugs of active agents |
| 04/24/2012 | US8163277 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants |
| 04/24/2012 | CA2700314C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/24/2012 | CA2614171C Copolymers for suppression of autoimmune diseases, and methods of use |
| 04/24/2012 | CA2573754C Substituted amino compounds as 5-ht/na uptake inhibitors |
| 04/24/2012 | CA2559530C Novel benzyl(idene)-lactam derivatives |
| 04/24/2012 | CA2525373C Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 04/24/2012 | CA2486537C 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds |
| 04/24/2012 | CA2480113C Substituted amino isoxazoline derivatives and their use as anti-depressants |
| 04/24/2012 | CA2473469C Tolerogenic peptides from myelin basic protein |
| 04/24/2012 | CA2457011C Treatment of glial tumors with glutamate antagonists |
| 04/24/2012 | CA2456601C Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 04/24/2012 | CA2433807C Hydrophobic polyamine analogs and methods for their use |
| 04/24/2012 | CA2433582C Peptides having inhibiting activity on the production of nitric oxide |
| 04/24/2012 | CA2425599C Fumaric acid amides |
| 04/19/2012 | WO2012051601A2 Heteroarylthio compounds |
| 04/19/2012 | WO2012051551A1 N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides |
| 04/19/2012 | WO2012051447A1 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders |
| 04/19/2012 | WO2012051296A2 Purine-based triazoles |
| 04/19/2012 | WO2012051213A2 Therapeutic 5,6,5-tricyclic analogs |
| 04/19/2012 | WO2012051139A1 New uses for substituted 2-amino-thiazolones in treating alzheimer's disease |
| 04/19/2012 | WO2012051111A2 Human oncostatin m antibodies and methods of use |
| 04/19/2012 | WO2012050944A2 Methods of treating chronic prostatitis/chronic pelvic pain syndrome |
| 04/19/2012 | WO2012050921A2 Nd2 peptides and methods of treating neurological disease |
| 04/19/2012 | WO2012050895A1 Methods for treating neurological disorders using nutrient compositions |
| 04/19/2012 | WO2012050623A2 Novel phenoxyisobutyric acid compounds and methods for synthesis |
| 04/19/2012 | WO2012050594A1 Treatment for cocaine addiction |
| 04/19/2012 | WO2012050517A1 Imidazole substituted pyrimidine having a high gsk3 inhibiting potency as well as pan-kinase selectivity |
| 04/19/2012 | WO2012050512A1 Trpa1 receptor antagonist |
| 04/19/2012 | WO2012050483A1 Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol |
| 04/19/2012 | WO2012050404A2 Composition containing ginseng and having nicotine removal effect |
| 04/19/2012 | WO2012050402A2 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same |
| 04/19/2012 | WO2012050380A2 Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof |
| 04/19/2012 | WO2012050151A1 Acylbenzene derivative |
| 04/19/2012 | WO2012049555A1 Spirocyclic compounds as voltage-gated sodium channel modulators |
| 04/19/2012 | WO2012049430A2 Hydrolysates of animal proteins of marine origin with neuroprotective properties |
| 04/19/2012 | WO2012049346A1 Hypocholesterolemic, anti-inflammatory and antiepileptic neuroprotective compound |
| 04/19/2012 | WO2012049332A1 Peptides and uses |
| 04/19/2012 | WO2012048710A1 Combinations of serotonin receptor agonists for treatment of movement disorders |
| 04/19/2012 | WO2012048417A1 Inhibitors of p75 receptor and their uses |
| 04/19/2012 | WO2012027326A9 Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin |
| 04/19/2012 | WO2012018635A3 Arylsulfonamide derivatives, compositions, and methods of use |
| 04/19/2012 | WO2012012798A3 Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases |
| 04/19/2012 | WO2012010974A3 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| 04/19/2012 | WO2012008733A3 Stem cells derived from primary placenta tissue and cellular therapeutic agent containing same |
| 04/19/2012 | WO2012006329A3 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 04/19/2012 | WO2012003452A3 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 04/19/2012 | WO2011163636A3 Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms |
| 04/19/2012 | WO2011163394A9 Compstatin analogs for treatment of neuropathic pain |
| 04/19/2012 | WO2011159871A3 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 04/19/2012 | WO2011156780A3 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/19/2012 | WO2011156775A3 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/19/2012 | WO2011156646A3 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/19/2012 | WO2011156518A3 Estrogen receptor modulators and uses thereof |
| 04/19/2012 | WO2011153502A3 Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them |
| 04/19/2012 | WO2011153157A3 Benzoquinolone inhibitors of vmat2 |
| 04/19/2012 | WO2011150229A3 Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity |
| 04/19/2012 | WO2011150156A3 Heteroaryl compounds and methods of use thereof |
| 04/19/2012 | WO2011146922A3 Materials and methods for treatment of inflammation |
| 04/19/2012 | US20120095388 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues |
| 04/19/2012 | US20120095386 Composition and device structure for iontophoresis |
| 04/19/2012 | US20120095235 Thioflavin derivates for use in the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 04/19/2012 | US20120095106 Preparation of chiral amides and amines |
| 04/19/2012 | US20120095105 Inhibitors of cognitive decline |
| 04/19/2012 | US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof |
| 04/19/2012 | US20120095095 Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs |
| 04/19/2012 | US20120095091 Antiepileptic, hypocholesterolemic and neuroprotective compound |
| 04/19/2012 | US20120095089 Schweinfurthins and uses thereof |
| 04/19/2012 | US20120095088 Medicinal cannabis uniform in food |
| 04/19/2012 | US20120095087 Enhanced products by sustainable processes for medicinal use |
| 04/19/2012 | US20120095084 Modulation of serotonin neurons involving the pet-1 transcriptional control region |